Long COVID abnormalities appear to resolve over time
Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have largely resolved by 24 months post-infection.
Source: labonline.com.au
Adapt Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Adapt Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Adapt Study Today - Breaking & Trending Today
Vyvgart Phase 3 Extension Study Data Affirm Long-Term Safety, Efficacy in gMG
Details from the final interim data analysis of the ADAPT+ study confirm previous findings seen with efgartigimod (Vyvgart) in generalized myasthenia gravis (gMG), the rare neuromuscular autoimmune disease.
Source: ajmc.com
Subanalysis of ADAPT Reveals Consistent Efficacy With Efgartigimod Among All Genders
Patients with generalized myasthenia gravis treated with efgartigimod consistently exceeded treatment compared with placebo regardless of gender in age, disease duration, body mass index, and thymectomy.
Source: ajmc.com